RU2010102722A - [(4'-NIKOTINOILAMINO) BUTIROILAMINO] BUTANIC ACID MANIFESTING NOOTROPIC ACTIVITY AND METHOD FOR PRODUCING IT - Google Patents

[(4'-NIKOTINOILAMINO) BUTIROILAMINO] BUTANIC ACID MANIFESTING NOOTROPIC ACTIVITY AND METHOD FOR PRODUCING IT Download PDF

Info

Publication number
RU2010102722A
RU2010102722A RU2010102722/04A RU2010102722A RU2010102722A RU 2010102722 A RU2010102722 A RU 2010102722A RU 2010102722/04 A RU2010102722/04 A RU 2010102722/04A RU 2010102722 A RU2010102722 A RU 2010102722A RU 2010102722 A RU2010102722 A RU 2010102722A
Authority
RU
Russia
Prior art keywords
producing
nikotinoilamino
butiroilamino
manifesting
nicotinoylamino
Prior art date
Application number
RU2010102722/04A
Other languages
Russian (ru)
Other versions
RU2436772C2 (en
Inventor
Исаак Григорьевич Гитлин (RU)
Исаак Григорьевич Гитлин
Наталия Юрьевна Горина (RU)
Наталия Юрьевна Горина
Никита Алексеевич Богословский (RU)
Никита Алексеевич Богословский
Original Assignee
Закрытое акционерное общество "НПК ЭХО" (RU)
Закрытое акционерное общество "НПК ЭХО"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "НПК ЭХО" (RU), Закрытое акционерное общество "НПК ЭХО" filed Critical Закрытое акционерное общество "НПК ЭХО" (RU)
Priority to RU2010102722/04A priority Critical patent/RU2436772C2/en
Publication of RU2010102722A publication Critical patent/RU2010102722A/en
Application granted granted Critical
Publication of RU2436772C2 publication Critical patent/RU2436772C2/en

Links

Abstract

1. 4[(4'-Никотиноиламино)бутироиламино]бутановая кислота формулы (I) ! ! проявляющая ноотропную активность. ! 2. Способ получения 4[(4'-никотиноиламино)бутироиламино]бутановой кислоты по п.1, заключающийся в том, что этиловый эфир N(4-никотиноиламино)бутановой кислоты подвергают взаимодействию с натриевой солью гамма-аминомасляной кислоты в среде органического растворителя. 1. 4 [(4'-Nicotinoylamino) butyroylamino] butanoic acid of the formula (I)! ! showing nootropic activity. ! 2. The method for producing 4 [(4'-nicotinoylamino) butyroylamino] butanoic acid according to claim 1, wherein the ethyl ester of N (4-nicotinoylamino) butanoic acid is reacted with the sodium salt of gamma-aminobutyric acid in an organic solvent.

Claims (2)

1. 4[(4'-Никотиноиламино)бутироиламино]бутановая кислота формулы (I)1. 4 [(4'-Nicotinoylamino) butyroylamino] butanoic acid of the formula (I)
Figure 00000001
Figure 00000001
 проявляющая ноотропную активность.showing nootropic activity. 2. Способ получения 4[(4'-никотиноиламино)бутироиламино]бутановой кислоты по п.1, заключающийся в том, что этиловый эфир N(4-никотиноиламино)бутановой кислоты подвергают взаимодействию с натриевой солью гамма-аминомасляной кислоты в среде органического растворителя. 2. The method for producing 4 [(4'-nicotinoylamino) butyroylamino] butanoic acid according to claim 1, wherein the ethyl ester of N (4-nicotinoylamino) butanoic acid is reacted with the sodium salt of gamma-aminobutyric acid in an organic solvent.
RU2010102722/04A 2010-01-28 2010-01-28 4[(4'-nicotinoylamino)butyroylamino]butanoic acid, exhibiting nootropic activity, and method of producing said compound RU2436772C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010102722/04A RU2436772C2 (en) 2010-01-28 2010-01-28 4[(4'-nicotinoylamino)butyroylamino]butanoic acid, exhibiting nootropic activity, and method of producing said compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010102722/04A RU2436772C2 (en) 2010-01-28 2010-01-28 4[(4'-nicotinoylamino)butyroylamino]butanoic acid, exhibiting nootropic activity, and method of producing said compound

Publications (2)

Publication Number Publication Date
RU2010102722A true RU2010102722A (en) 2011-08-10
RU2436772C2 RU2436772C2 (en) 2011-12-20

Family

ID=44754015

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010102722/04A RU2436772C2 (en) 2010-01-28 2010-01-28 4[(4'-nicotinoylamino)butyroylamino]butanoic acid, exhibiting nootropic activity, and method of producing said compound

Country Status (1)

Country Link
RU (1) RU2436772C2 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9303038B2 (en) 2011-09-06 2016-04-05 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological diseases
CN104350041A (en) 2012-05-07 2015-02-11 塞利克斯比奥私人有限公司 Compositions and methods for the treatment of neurological disorders
AU2013257742A1 (en) 2012-05-07 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
WO2013167990A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of depression
WO2013168023A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of parkinson's disease
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
WO2013167991A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic disorders
US9403826B2 (en) 2012-05-08 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory disorders
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9573927B2 (en) 2012-05-10 2017-02-21 Cellix Bio Private Limited Compositions and methods for the treatment of severe pain
US9242939B2 (en) 2012-05-10 2016-01-26 Cellix Bio Private Limited Compositions and methods for the treatment of respiratory disorders
WO2013168002A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological conditions
SG11201407318UA (en) 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of metabolic syndrome
US9499527B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013167997A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
WO2013168001A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
WO2013168015A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of asthma and allergy
WO2013168033A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neurologic diseases
US9227974B2 (en) 2012-05-23 2016-01-05 Cellex Bio Private Limited Compositions and methods for the treatment of respiratory disorders
CA2873096A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
CA2873098A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9434729B2 (en) 2012-05-23 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9492409B2 (en) 2012-05-23 2016-11-15 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
AU2013264820A1 (en) 2012-05-23 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of mucositis
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en) * 2012-08-03 2014-02-06 Mahesh Kandula Compositions and methods for the treatment migraine and neurologic diseases
US9624168B2 (en) 2012-09-06 2017-04-18 Cellix Bio Private Limited Compositions and methods for the treatment inflammation and lipid disorders
WO2014037834A2 (en) 2012-09-08 2014-03-13 Mahesh Kandula Compositions and methods for the treatment of inflammation and lipid disorders
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
CA2914461A1 (en) 2013-06-04 2014-12-11 Cellixbio Private Limited Compositions and methods for the treatment of diabetes and pre-diabetes
WO2016110865A1 (en) 2015-01-06 2016-07-14 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation and pain
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
RU2550960C1 (en) * 2014-05-20 2015-05-20 Общество с Ограниченной Ответственностью "НПК ЭХО" Pharmaceutical composition, possessing gaba-ergic activity
EP3240779B1 (en) 2014-09-26 2020-10-28 Cellixbio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
JP6698643B2 (en) 2014-09-29 2020-05-27 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ Compositions and methods for the treatment of multiple sclerosis
CA2965449C (en) 2014-10-27 2020-11-10 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
RU2641102C1 (en) * 2017-03-13 2018-01-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ New water-soluble salicylamide derivative with neuroprotective action in case of cerebral circulation insufficiency

Also Published As

Publication number Publication date
RU2436772C2 (en) 2011-12-20

Similar Documents

Publication Publication Date Title
RU2010102722A (en) [(4'-NIKOTINOILAMINO) BUTIROILAMINO] BUTANIC ACID MANIFESTING NOOTROPIC ACTIVITY AND METHOD FOR PRODUCING IT
EA201291436A1 (en) DERIVATIVES OF CARBAMATE HEXAFLUOROPIROPIL, THEIR RECEIVING AND THEIR THERAPEUTIC APPLICATION
BRPI0918299A2 (en) Method to Produce an L-Amino Acid
RU2010154144A (en) EXTERIOR FOR SKIN
TR201903978T4 (en) L-ornithine phenyl acetate making methods.
BR112013020609A2 (en) Storage stable 2-hydroxy-4- (methylthio) butyronitrile
BRPI0912755A2 (en) Method to Produce an L-Amino Acid
BR112013003216A2 (en) synthetic bile acid compositions and methods
RU2015118163A (en) A NEW ALICYCLIC DIOL COMPOUND AND METHOD FOR PRODUCING IT
EA201071001A1 (en) METHOD OF OBTAINING COMBRESTASTATIN
BR112013031496A2 (en) amino acid composition
RU2008105019A (en) N-SUBSTITUTED 4-METHYL-2,6-DICHLORONICOTINOIL-UREA AS AN ANIDOT 2,4-D IN SUNFLOWER
RU2015118152A (en) NEW COMPOUND ETHERIC COMPOUND OF ALICYCLIC DICARBOXYLIC ACID AND METHOD FOR ITS MANUFACTURE
RU2011132708A (en) AROMATIC BLOCK-COPOLYETHERSULPHONES
EA200800861A1 (en) METHOD OF OBTAINING QUARTERLY AMMONIUM SALTS WITH ACID
EA201300100A2 (en) METHOD OF ENZYMATIC SYNTHESIS OF (7S) -3,4-DIMETOXYBICYCLO [4.2.0] OCTA-1,3,5-TRIEN-7-CARBONIC ACID OR ITS COMPLEX ESTERS AND APPLICATION FOR SYNTHESIS OF IVABRADINE AND ITS SALT
BR112013026747A2 (en) process and appliance
BRPI0909752B8 (en) processes for the production of sulfonylpyrroles as HDAC inhibitors and a pharmaceutical composition comprising the same
RU2012144244A (en) METHOD FOR ENANTIOSELECTIVE SYNTHESIS OF (S) -PREBABALIN
RU2011151143A (en) AROMATIC BLOCK-COPOLIETHYRKETONES
RU2008105610A (en) METHODS FOR PRODUCING N-Acyl DERIVATIVES OF AMINO ACIDS (OPTIONS)
RU2010141921A (en) Ethyl 2-Ethyl-2- (1-oxo-5-phenyl-2-oxaspiro [5.5] undec-3-en-3-yl) butanoate, which exhibits analgesic activity and preparation
RU2013124654A (en) AMINOAMIDES IN THE SERIES OF BACTERIOCHLOROPHYL ALPHA WITH PHOTODYNAMIC ACTIVITY AND METHOD FOR PRODUCING THEM
RU2011137176A (en) 2-AMINO-5-CHLORBENZOATE 2-HYDROXYPROPYLTRIETHYLAMMONIUM, POSSESSING BIOLOGICAL ACTIVITY AND METHOD FOR PRODUCING IT
RU2009149491A (en) 2,3-DICHLOR-4 - [(6-CHLORO-5-CYANO-4-METHYLPYRIDYL-2) -METHYLHRAZONO] -BUTENE-2-ACID ACID AS A 2,4-D ANTIDOTE ON SUNFLOWER

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20120129

NF4A Reinstatement of patent

Effective date: 20130227

MM4A The patent is invalid due to non-payment of fees

Effective date: 20180129

NF4A Reinstatement of patent

Effective date: 20190312